046 - "Inflation Reduction Act" with Sarfaraz Niazi

Let's Combinate · 17 Aug 2022 · 32m

What this episode covers

Dr. Sarfaraz Niazi, founder of Pharmaceutical Scientist Inc. and Adello Biologics, explains the provisions of the Inflation Reduction Act, specifically the $2,000 out-of-pocket cap for Medicare Part D and the $35 monthly cap on insulin. He clarifies that the bill allows CMS to negotiate prices for 10 drugs rather than imposing price controls, arguing this will not harm pharmaceutical profits or innovation. Niazi also discusses the distinction between Medicare and private insurance reimbursement models and advocates for extending insulin caps to private markets.

Most relevant to

established companies

Topics

Mentioned

Companies
Pharmaceutical Scientist Inc., Adello Biologics, Kashiv Biosciences
Products
MayaBio
Also
Inflation Reduction Act, CMS, Medicare, Affordable Care Act

Other shows on the same ground, closest first.

  • How I Built This · 34m

    HIBT Lab! Mark Cuban Cost Plus Drug Company: Mark Cuban

    Serial entrepreneur Mark Cuban discusses his newest venture, the Mark Cuban Cost Plus Drug Company (MCCPDC), which he co-founded with radiologist Alex Oshmiansky to disrupt the pharmaceutical industry by offering generic drugs at transparent, low costs. Cuban explains how he educated himself on the complex drug pricing ecosystem, identifying Pharmacy Benefit Managers (PBMs) and vertically integrated insurance companies as the primary drivers of inflated prices rather than manufacturing costs. He details the company's business model as a public benefit corporation that charges a flat 15% markup plus handling and shipping fees, bypassing traditional insurance rebates to undercut standard co-pays. Cuban also touches on his interest in NFTs, his strategy for staying grounded through social media feedback, and his belief that wealthy individuals have a responsibility to fund solutions for systemic problems like high drug prices.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Let's Combinate. The episode itself belongs to its publisher.